These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 421174)

  • 1. Electrocardiographic changes after adriamycin chemotherapy.
    Ali MK; Soto A; Maroongroge D; Bekheit-Saad S; Buzdar AU; Blumenschein GR; Hortobagyi GN; Tashima CK; Wiseman CL; Shullenberger CC
    Cancer; 1979 Feb; 43(2):465-71. PubMed ID: 421174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QRS voltage change with adriamycin administration.
    Minow RA; Benjamin RS; Lee ET; Gottlieb JA
    Cancer Treat Rep; 1978 Jun; 62(6):931-4. PubMed ID: 667870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity.
    Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ
    Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adriamycin cardiomyopathy--risk factors.
    Minow RA; Benjamin RS; Lee ET; Gottlieb JA
    Cancer; 1977 Apr; 39(4):1397-402. PubMed ID: 856438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical observation of electrocardiographic changes in response to taxotere combined with adriamycin treatment for breast cancer].
    Huang ZQ; Li HX; Wang JL; Wan SG
    Di Yi Jun Yi Da Xue Xue Bao; 2004 May; 24(5):582-3. PubMed ID: 15151841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electrocardiogram analysis of adriamycin cardiotoxicity in 160 cases].
    Wang SQ
    Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):71-3. PubMed ID: 1889343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic changes following adriamycin treatment.
    Dindogru A; Barcos M; Henderson ES; Wallace HJ
    Med Pediatr Oncol; 1978; 5(1):65-71. PubMed ID: 745592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total 12-Lead QRS Voltage in Patients Having Orthotopic Heart Transplantation for Heart Failure Caused by Adriamycin-Induced Cardiomyopathy.
    Roberts WC; Haque S; Hall SA
    Cardiology; 2018; 141(3):172-175. PubMed ID: 30650419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protective effect of coenzyme Q10 in cardiotoxicity induced by adriamycin].
    Okuma K; Furuta I; Ota K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):502-8. PubMed ID: 6703724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience.
    Ibrahim NK; Hortobagyi GN; Ewer M; Ali MK; Asmar L; Theriault RL; Fraschini G; Frye DK; Buzdar AU
    Cancer Chemother Pharmacol; 1999; 43(6):471-8. PubMed ID: 10321507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adriamycin cardiomyopathy in a child with Wilms tumor and liver metastases (author's transl)].
    Stopfkuchen H; Gutjahr P
    Klin Padiatr; 1976 Sep; 188(5):459-63. PubMed ID: 184344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
    Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
    Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adriamycin and mitomycin C: possible synergistic cardiotoxicity.
    Buzdar AU; Legha SS; Tashima CK; Hortobagyi GN; Yap HY; Krutchik AN; Luna MA; Blumenschein GR
    Cancer Treat Rep; 1978 Jul; 62(7):1005-8. PubMed ID: 688243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiotoxicity of mitoxantrone].
    Okuma K; Ariyoshi Y; Ota K
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3040-5. PubMed ID: 3464231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Noninvasive cardia fúnction diagnosis in children treated with adriamycin (author's transl)].
    Schmaltz AA; Treuner J; Class U; Heil RP
    Klin Padiatr; 1980 Nov; 192(6):502-8. PubMed ID: 7194391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adriamycin, cardiotoxicity--a case report].
    Okuma K; Ota K
    Gan To Kagaku Ryoho; 1982 May; 9(5):936-41. PubMed ID: 6307186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A paucity of chronic electrocardiographic changes with adriamycin therapy.
    Weaver SK; Fulkerson PK; Lewis RP; Leier CV
    J Electrocardiol; 1978 Jul; 11(3):233-8. PubMed ID: 690550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval).
    Greco FA; Brereton HD; Rodbard D
    Cancer Treat Rep; 1976 Sep; 60(9):1239-45. PubMed ID: 797446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congestive heart failure due to adriamycin cardiotoxicity: its natural history in children.
    Goorin AM; Borow KM; Goldman A; Williams RG; Henderson IC; Sallan SE; Cohen H; Jaffe N
    Cancer; 1981 Jun; 47(12):2810-6. PubMed ID: 6942908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.
    Buzzoni R; Bonadonna G; Valagussa P; Zambetti M
    J Clin Oncol; 1991 Dec; 9(12):2134-40. PubMed ID: 1960555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.